Nimjee, Shahid M <br/><br/>
A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Sep 2006 
 - 408-15 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-0016 
<br/><br/><label>Standard No.: </label>10.1016/j.ymthe.2006.04.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anticoagulants--administration & dosage<br/>Antidotes--administration & dosage<br/>Aptamers, Nucleotide--administration & dosage<br/>Blood Coagulation--drug effects<br/>Cardiopulmonary Bypass<br/>Factor IXa--antagonists & inhibitors<br/>Heart--drug effects<br/>Heparin--pharmacology<br/>Models, Animal<br/>Nucleic Acid Conformation<br/>Protamines--metabolism<br/>Swine<br/>Thrombin--antagonists & inhibitors